ACE2 and infection: This molecule was able to block better the in vitro infection with SARS-CoV-2 VOCs (microneutralization assay with authentic virus), respect D614G strain, which suggests the potentialities of this therapeutic for being used against the current and emerging variants that maintain ACE2 as the entry portal to human cells.